The association of p63 expression with high-risk IPI in GCB-DLBCL, and thus affecting its apparent prognostic effects in GCB and overall DLBCL, may contribute to the inconsistent findings from previous studies. The gene discussed is TP63; the disease is diffuse large B-cell lymphoma.